Upexi Inc (UPXI) AI Stock Analysis

Headquartered in Clearwater, Florida, Upexi Inc specializes in manufacturing and selling a diverse range of branded products across multiple markets, including health, wellness, pet care, and beauty. Originally incorporated in 2018 under the name Grove, Inc., the company rebranded to Upexi, Inc. in August 2022. Its product portfolio spans categories such as dietary supplements, personal care items, pet accessories, and specialized beauty products. Upexi leverages strategic partnerships and research and development to expand its offerings and maintain a competitive edge in consumer goods, operating with 10 employees.

Upexi generated $25.0M in revenue in FY2026, representing an increase of 58.1% from $15.8M in FY2025, following a decline of 28.7% in FY2024. Over the five years from FY2021 to FY2026, revenue CAGR was 0.7%. Gross margin expanded to 87.7% in FY2026, up from 68.7% in FY2025 and 49.3% in FY2024. Operating margin remained negative at -127.6%, and net income stood at -$246.1M, yielding a net margin of -984.3%. For the latest quarter ended June 30, 2026, quarterly revenue fell 26.6% year-over-year, while quarterly earnings growth was 3572.8%.

As of June 30, 2026, Upexi held $5.8M in cash and short-term investments alongside total debt of $223.7M, resulting in net debt of $217.9M. Shareholders' equity was negative at -$53.8M against total assets of $180.1M, with a current ratio of 1.64. In FY2026, operating cash flow was -$21.0M and free cash flow was -$21.0M. Capital deployment included $44,000 for capital expenditures and $2.8M for share buybacks, while the five-year share count change was 12925.7%.

At the last close of $0.97 on October 16, 2026, Upexi had a market capitalization of $80.0M and an enterprise value of $314.4M. Its forward P/E stands at 243.9x, compared to the 14.1x median of its US-listed Communication Services peers. The stock trades at a price-to-sales multiple of 3.2x versus the peer median of 0.8x, and an EV-to-EBITDA multiple of 290.2x against the peer median of 10.0x. Over the trailing 12 months, the stock fell 82.6%, trailing the S&P 500 (SPY) return of 16.8%.

Wall Street analyst coverage includes 1 Strong Buy rating, 0 Buy, 0 Hold, 0 Sell, and 0 Strong Sell ratings. The mean price target is $2.00, representing 105.3% upside compared to the last close of $0.97. For the fiscal year ending June 30, 2027, the consensus revenue estimate is $26.7M with an EPS estimate of -$0.43. For the following fiscal year, revenue is projected at $43.6M with an EPS estimate of -$0.13. The company beat EPS estimates in 1 of the last 4 quarters, and the next earnings date is November 10, 2026.

This page is an AI-written research summary of Upexi Inc (UPXI). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: UPXI income statement, UPXI balance sheet, UPXI key metrics, UPXI analyst forecast, UPXI chart. See the UPXI stock overview for the latest quote and news.